Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOWLES, DAVID PAUL | 1 | 69.4% | +25.9% |
| VALLE, ERNESTO | 1 | 56.0% | +41.3% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| MEYERING, SHABANA SHABBEER | 1 | 69.7% | +41.8% |
| BEANE, RANDALL L | 1 | 32.8% | +36.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18356591 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | BRETZ, COREY LANE | — |
| 18314761 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | MEYERING, SHABANA SHABBEER | — |
| 17285039 | AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA | BEANE, RANDALL L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18372753 | METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | VALLE, ERNESTO | 34d |
| 19420848 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA | BOWLES, DAVID PAUL | — |
| 18314761 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | MEYERING, SHABANA SHABBEER | — |
| 17285039 | AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA | BEANE, RANDALL L | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1635 | 2 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19420848 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA | BOWLES, DAVID PAUL | 1654 | §103DP | Final Rejection | — | Pending | Dec 16, 2025 |
| 18372753 | METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | VALLE, ERNESTO | 1623 | §103Other | Non-Final OA | 34d | Pending | Sep 26, 2023 |
| 18356591 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | BRETZ, COREY LANE | 1635 | §103 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18314761 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | MEYERING, SHABANA SHABBEER | 1635 | §102§103§112 | Non-Final OA | — | Pending | May 09, 2023 |
| 17285039 | AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA | BEANE, RANDALL L | 1654 | §103§112Other | Non-Final OA | — | Pending | Apr 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial